vs
Side-by-side financial comparison of Hilltop Holdings Inc. (HTH) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $300.5M, roughly 1.6× Hilltop Holdings Inc.). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 6.8%, a 6.2% gap on every dollar of revenue. Over the past eight quarters, Hilltop Holdings Inc.'s revenue compounded faster (0.6% CAGR vs -0.1%).
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
HTH vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $300.5M | $493.8M |
| Net Profit | $39.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 13.0% | 6.8% |
| Revenue YoY | — | -1.7% |
| Net Profit YoY | -12.4% | 10.5% |
| EPS (diluted) | $0.64 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $300.5M | — | ||
| Q4 25 | $329.9M | $493.8M | ||
| Q3 25 | $330.2M | $492.9M | ||
| Q2 25 | $303.3M | $468.8M | ||
| Q1 25 | $318.5M | $458.4M | ||
| Q4 24 | $301.1M | $502.4M | ||
| Q3 24 | $305.5M | $511.2M | ||
| Q2 24 | $297.0M | $504.3M |
| Q1 26 | $39.0M | — | ||
| Q4 25 | $41.6M | $33.7M | ||
| Q3 25 | $45.8M | $71.7M | ||
| Q2 25 | $36.1M | $39.3M | ||
| Q1 25 | $42.1M | $20.7M | ||
| Q4 24 | $35.5M | $30.5M | ||
| Q3 24 | $29.7M | $19.4M | ||
| Q2 24 | $20.3M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | 16.1% | 9.9% | ||
| Q3 25 | 18.4% | 13.8% | ||
| Q2 25 | 16.3% | 12.8% | ||
| Q1 25 | 18.1% | 7.0% | ||
| Q4 24 | 14.7% | 7.8% | ||
| Q3 24 | 13.9% | 6.6% | ||
| Q2 24 | 10.0% | -31.3% |
| Q1 26 | 13.0% | — | ||
| Q4 25 | 12.6% | 6.8% | ||
| Q3 25 | 13.9% | 14.5% | ||
| Q2 25 | 11.9% | 8.4% | ||
| Q1 25 | 13.2% | 4.5% | ||
| Q4 24 | 11.8% | 6.1% | ||
| Q3 24 | 9.7% | 3.8% | ||
| Q2 24 | 6.8% | -30.3% |
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.68 | $0.40 | ||
| Q3 25 | $0.74 | $0.84 | ||
| Q2 25 | $0.57 | $0.46 | ||
| Q1 25 | $0.65 | $0.24 | ||
| Q4 24 | $0.55 | $0.37 | ||
| Q3 24 | $0.46 | $0.23 | ||
| Q2 24 | $0.31 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | $990.8M | $570.5M |
| Stockholders' EquityBook value | $2.2B | $865.9M |
| Total Assets | $15.7B | $2.2B |
| Debt / EquityLower = less leverage | 0.46× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
| Q1 26 | $990.8M | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $865.9M | ||
| Q3 25 | $2.2B | $890.7M | ||
| Q2 25 | $2.2B | $833.8M | ||
| Q1 25 | $2.2B | $789.2M | ||
| Q4 24 | $2.2B | $764.9M | ||
| Q3 24 | $2.2B | $732.5M | ||
| Q2 24 | $2.1B | $706.5M |
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.8B | $2.2B | ||
| Q3 25 | $15.6B | $2.2B | ||
| Q2 25 | $15.4B | $2.1B | ||
| Q1 25 | $15.8B | $2.0B | ||
| Q4 24 | $16.3B | $2.2B | ||
| Q3 24 | $15.9B | $2.1B | ||
| Q2 24 | $15.6B | $2.0B |
| Q1 26 | 0.46× | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-38.7M | $114.1M | ||
| Q3 25 | $273.0M | $137.3M | ||
| Q2 25 | $-234.6M | $137.2M | ||
| Q1 25 | $5.8M | $-117.5M | ||
| Q4 24 | $273.9M | $133.0M | ||
| Q3 24 | $515.6M | $91.8M | ||
| Q2 24 | $-435.3M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-55.5M | — | ||
| Q3 25 | $271.0M | — | ||
| Q2 25 | $-234.6M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $266.8M | — | ||
| Q3 24 | $513.8M | — | ||
| Q2 24 | $-437.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | — | ||
| Q3 25 | 82.1% | — | ||
| Q2 25 | -77.4% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 88.6% | — | ||
| Q3 24 | 168.2% | — | ||
| Q2 24 | -147.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.93× | 3.39× | ||
| Q3 25 | 5.96× | 1.91× | ||
| Q2 25 | -6.50× | 3.49× | ||
| Q1 25 | 0.14× | -5.66× | ||
| Q4 24 | 7.71× | 4.36× | ||
| Q3 24 | 17.36× | 4.72× | ||
| Q2 24 | -21.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |